The developed method has already been applied to a large subset of the BCR database, providing receptor status for more than 200,000 breast cancer reports (incidence period 2008–2017), allowing to perform more focused real-world population-based studies of quality of care for breast cancer diagnostic, prognostic assessment as well as clinical management (10). Here, BCR is linked to breast cancer.